Nucleoprotein 118-126

Nucleoprotein 118-126 is a synthetic peptide fragment corresponding to amino acid residues 118 to 126 of a nucleoprotein sequence, typically derived from viral sources such as influenza or coronaviruses. As a defined peptide epitope, it holds significant value in immunological and virological research, enabling precise interrogation of antigenic regions involved in host-pathogen interactions. Researchers leverage this fragment to dissect immune recognition, T-cell responses, and antibody specificity, making it a critical tool for advancing molecular understanding of viral protein function and immune surveillance mechanisms. The sequence-specific nature of Nucleoprotein 118-126 allows for targeted applications in both basic and applied studies focusing on host immune dynamics and viral protein characterization.

Epitope Mapping: Nucleoprotein 118-126 serves as a valuable probe for mapping B-cell and T-cell epitopes within nucleoprotein antigens. By using this peptide in immunoassays, researchers can identify immune-dominant regions recognized by antibodies or T-cell receptors, facilitating the characterization of immune responses to viral infections. Such mapping is essential for understanding the specificity and breadth of immune recognition, which can inform rational design of diagnostic reagents and support fundamental investigations into antigen processing and presentation.

Immunogenicity Assessment: The defined peptide sequence is frequently employed to assess the immunogenic potential of nucleoprotein-derived epitopes. In vitro stimulation assays and ex vivo immune profiling can utilize this fragment to evaluate T-cell activation, cytokine production, and memory response formation. These studies help elucidate the mechanisms by which host immunity targets conserved viral regions, supporting efforts to identify robust immunological markers and inform vaccine candidate evaluation in preclinical research.

Antibody Specificity Studies: Researchers utilize Nucleoprotein 118-126 to test the specificity and cross-reactivity of monoclonal or polyclonal antibodies generated against nucleoprotein antigens. By incorporating the peptide into ELISA, western blot, or peptide array platforms, it becomes possible to distinguish between antibodies that recognize linear versus conformational epitopes. This application aids in the refinement of antibody-based assays and enhances the reliability of immunodetection tools for virological research.

Peptide-MHC Binding Analysis: The peptide fragment is instrumental in studies of peptide-major histocompatibility complex (MHC) binding. Investigators can use Nucleoprotein 118-126 to assess its affinity for various MHC class I or II molecules, thereby modeling antigen presentation pathways relevant to cellular immunity. Such analyses are central to understanding how specific viral epitopes are displayed to T cells and can inform computational and experimental approaches to epitope prediction.

Synthetic Peptide Controls: In experimental workflows, Nucleoprotein 118-126 is commonly employed as a synthetic control in assay development and validation. Its well-defined sequence and biochemical properties make it suitable as a positive control for peptide-based immunoassays, mass spectrometry calibration, or functional screening protocols. The use of standardized peptide controls ensures reproducibility across experiments and supports quality assurance in both academic and industrial research settings.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma